Mwanzo08HH • FRA
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Bei iliyotangulia
€ 1.64
Bei za siku
€ 1.64 - € 1.65
Bei za mwaka
€ 1.29 - € 2.32
Thamani ya kampuni katika soko
62.83B HKD
Wastani wa hisa zilizouzwa
162.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 10.16B | -5.09% |
Matumizi ya uendeshaji wa biashara | 4.25B | -14.46% |
Mapato halisi | 759.24M | 635.70% |
Kiwango cha faida halisi | 7.48 | 679.17% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.00B | 115.25% |
Asilimia ya kodi ya mapato | 9.46% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 16.12B | 3.45% |
Jumla ya mali | 117.46B | 3.52% |
Jumla ya dhima | 57.53B | 1.18% |
Jumla ya hisa | 59.93B | — |
hisa zilizosalia | 2.66B | — |
Uwiano wa bei na thamani | 0.09 | — |
Faida inayotokana na mali | 0.79% | — |
Faida inayotokana mtaji | 0.96% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 759.24M | 635.70% |
Pesa kutokana na shughuli | 1.49B | 56.45% |
Pesa kutokana na uwekezaji | -1.17B | -119.37% |
Pesa kutokana na ufadhili | -500.30M | 46.76% |
Mabadiliko halisi ya pesa taslimu | -85.94M | 85.18% |
Mtiririko huru wa pesa | 2.92B | 9.19% |
Kuhusu
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1994
Tovuti
Wafanyakazi
40,557
